Dr. Aimetti talks about the clinical and pre-clinical advancements made by InVivo Therapeutics to develop treatments for acute and chronic spinal cord injury.
Alex Aimetti, PhD, is Senior Director, Medical Education and Scientific Support at InVivo Therapeutics. InVivo is a research and clinical-stage biomaterials and biotechnology company with a focus on innovative treatment approaches for spinal cord injury (SCI). Alex joined InVivo in 2012 and currently serves as the lead for all professional medical education programs that aim to build company, technology, and product awareness. Alex’s scientific research has resulted in over 40 top-tiered scientific publications, conference presentations, and patent applications within the biomaterials and regenerative medicine fields. Prior to joining InVivo, Alex completed his post-doctoral fellowship in the lab of Robert Langer at the Massachusetts Institute of Technology (MIT). Alex has a PhD in Chemical Engineering and a BS in Biomedical Engineering.